Vivos Therapeutics, Inc. (VVOS)
USD 4.54
(-7.35%)
USD 4.54
(-7.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 13.8 Million | 16.02 Million | 16.88 Million | 13.06 Million | 11.39 Million | 3.79 Million |
| Cost of Revenue | 5.53 Million | 6 Million | 4.28 Million | 2.65 Million | 2.73 Million | 1.08 Million |
| Gross Profit | 8.27 Million | 10.01 Million | 12.6 Million | 10.41 Million | 8.65 Million | 2.71 Million |
| Operating Expenses | 24.94 Million | 35.05 Million | 32.07 Million | 19.12 Million | 19.23 Million | 11.04 Million |
| Selling, General and Administrative Expenses | 24.84 Million | 34.38 Million | 31.34 Million | 18.4 Million | 18.48 Million | 10.43 Million |
| Research and Development Expenses | 100 Thousand | 200 Thousand | - | - | - | - |
| Other Expenses | 621 Thousand | 669 Thousand | 733 Thousand | 717.86 Thousand | 751.22 Thousand | 610.67 Thousand |
| Cost and Expenses | 31.09 Million | 41.05 Million | 36.35 Million | 21.77 Million | 21.97 Million | 12.12 Million |
| Operating Income | -17.29 Million | -25.03 Million | -19.47 Million | -8.7 Million | -10.57 Million | -8.33 Million |
| Interest Expense | - | - | 14 Thousand | 96.68 Thousand | 137.87 Thousand | 102.97 Thousand |
| Income Tax Expense | - | -1.18 Million | 5000.00 | -3.23 Million | 137.87 Thousand | 102.97 Thousand |
| Earnings before Tax | -13.58 Million | -23.84 Million | -20.28 Million | -12.05 Million | -10.75 Million | -8.43 Million |
| Net Income | -13.58 Million | -22.65 Million | -20.29 Million | -8.82 Million | -10.89 Million | -8.54 Million |
| Earnings Per Share Basic | -11.14 | -24.62 | -23.89 | -12.11 | -21.94 | -18.49 |
| Earnings Per Share Diluted | -11.14 | -24.62 | -23.89 | -12.11 | -21.94 | -18.49 |
| Weighted Average Shares Outstanding | 1.21 Million | 920.48 Thousand | 849.32 Thousand | 728.37 Thousand | 496.42 Thousand | 461.92 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 1.21 Million | 920.48 Thousand | 849.32 Thousand | 728.37 Thousand | 496.42 Thousand | 461.92 Thousand |
| Gross Margin | 0.60 | 0.63 | 0.75 | 0.80 | 0.76 | 0.71 |
| EBIT Margin | -1.21 | -1.53 | -1.10 | -0.86 | -0.86 | -2.04 |
| Profit Margin | -0.98 | -1.41 | -1.20 | -0.68 | -0.96 | -2.25 |
| EBITDA | -16.67 Million | -24.36 Million | -19.54 Million | -11.24 Million | -9.86 Million | -7.72 Million |
| Earnings Before Tax Margin | -1.25 | -1.56 | -1.15 | -0.67 | -0.93 | -2.20 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 4.05 Million | 3.41 Million | 13.8 Million | 3.24 Million | 3.3 Million | 3.39 Million |
| Cost of Revenue | 1.54 Million | 1.48 Million | 6.15 Million | 1.45 Million | 1.4 Million | 1.29 Million |
| Gross Profit | 2.5 Million | 1.93 Million | 7.65 Million | 1.78 Million | 1.89 Million | 2.09 Million |
| Operating Expenses | 4.44 Million | 5.57 Million | 24.94 Million | 6.07 Million | 5.38 Million | 6.61 Million |
| Selling, General and Administrative Expenses | 4.44 Million | 5.57 Million | - | 6.07 Million | 5.23 Million | 6.46 Million |
| Research and Development Expenses | - | 100 Thousand | - | 100 Thousand | 100 Thousand | 100 Thousand |
| Other Expenses | 6000.00 | 22 Thousand | -65 Thousand | 5000.00 | -53 Thousand | -144 Thousand |
| Cost and Expenses | 5.99 Million | 7.05 Million | 31.09 Million | 7.53 Million | 6.79 Million | 7.91 Million |
| Operating Income | -1.93 Million | -3.63 Million | -17.29 Million | -4.28 Million | -3.48 Million | -4.51 Million |
| Interest Expense | - | - | - | 3.3 Million | - | - |
| Income Tax Expense | - | 1.43 Million | 453.1 Thousand | 7.05 Million | -1.44 Million | 867 Thousand |
| Earnings before Tax | -1.93 Million | -3.76 Million | -13.58 Million | -4.25 Million | -2.09 Million | -5.52 Million |
| Net Income | -1.93 Million | -3.76 Million | -13.58 Million | -4.25 Million | -2.09 Million | -5.52 Million |
| Earnings Per Share Basic | -0.60 | -1.63 | - | -2.32 | -1.75 | -4.62 |
| Earnings Per Share Diluted | -0.60 | -1.63 | - | -2.32 | -1.75 | -4.62 |
| Weighted Average Shares Outstanding | 3.22 Million | 2.3 Million | 1.21 Million | 1.83 Million | 1.19 Million | 1.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.22 Million | 2.3 Million | 1.21 Million | 1.83 Million | 1.19 Million | 1.19 Million |
| Gross Margin | 0.62 | 0.57 | 0.55 | 0.55 | 0.57 | 0.62 |
| EBIT Margin | -0.44 | -0.63 | - | -1.27 | -1.45 | -1.03 |
| Profit Margin | -0.48 | -1.10 | -0.98 | -1.31 | -0.63 | -1.63 |
| EBITDA | -1.79 Million | -2.15 Million | - | -4.13 Million | -4.78 Million | -3.5 Million |
| Earnings Before Tax Margin | -0.48 | -1.06 | -1.25 | -1.32 | -1.06 | -1.33 |
ECXJ
KMDA
KTMS
ELRA
TAND
AIIL